Fig. 5From: DPYSL2 as potential diagnostic and prognostic biomarker linked to immune infiltration in lung adenocarcinomaImmune-related signal pathways enriched in the DPYSL2 high expression group of LUAD. Immune-related signal pathways enriched in LUAD patients with high DPYSL2 phenotype were activation of immune response (A), adaptive immune response (B), immune receptor activity (C), T cell activation (D), macrophage activation (E), and T cell-mediated immunity (F)Back to article page